Psychemedics Revenue, Profits - PMD Quarterly Income Statement

Add to My Stocks
$20.97 $0.32 (1.5%) PMD stock closing price Feb 20, 2018 (Closing)

Looking at financial statements, along with the Psychemedics stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the PMD stock is bound to reflect the impact of the QOQ growth of 3.82%. One also needs to look at Psychemedics assets, operating expenses and Psychemedics free cash flow. The Psychemedics profit and loss statement shows revenue of $10.05M for 2017 Q3. Revenue has grown by 3.82% QoQ for PMD stock.

View and download details of revenue and profits for Psychemedics for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Psychemedics Revenues or Net Sales
Cost Of Goods Sold (COGS)4.92M5.07M4.89M4.38M4.74M4.49M3.92M3.49M3.62M
Psychemedics Gross Profit
Research & Development Expense---------
Selling General & Admin Expense2.53M2.57M2.71M2.42M2.65M2.48M2.37M2.2M2.51M
Income Before Depreciation Depletion Amortization2.23M1.71M2.26M3.64M4.1M2.37M---
Depreciation Depletion Amortization---------
Non Operating Income----0.13M----0.03M-0.03M
Interest Expense----0.09M-----
Psychemedics Pretax Income
Provision for Income Taxes---1.24M1.36M--0.01M-0.09M-0.27M
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations1.36M-1.5M2.36M2.71M1.63M-0.02M--
Extraordinary Items & Discontinued Operations---------
Psychemedics Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS5.46M5.34M5.56M5.49M5.51M5.45M5.42M5.42M5.43M
Average Shares used to compute Basic EPS5.46M5.34M5.56M5.49M5.46M5.44M5.42M5.42M5.42M
Income Before Nonrecurring Items1.36M-1.5M2.36M2.71M1.63M-0.02M--
Income from Nonrecurring Items---------
Psychemedics Earnings Per Share Basic Net
Psychemedics Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items0.
Preferred Dividends Acc Pd---------
Dividends Common0.82--------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Before investing one should read a report on Psychemedics stock analysis. It helps to look at the following income statement items:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $10.05M for this quarter of 2017 Q3. Our Psychemedics revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $1.36M for Psychemedics for 2017 Q3. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called the profit and loss statement. Apart from the PMD income statement, one can check the Psychemedics historical stock prices to check how the price has moved with time.

Psychemedics Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
PS Ratio (price sales ratio)
Operating Margin
Net Profit Margin
Dividend Yield